Literature DB >> 17990725

Inappropriate polypharmacy: reducing the burden of multiple medication.

James C Milton1, Stephen H D Jackson.   

Abstract

Mesh：

Year:  2007        PMID： 17990725      PMCID： PMC4953055          DOI： 10.7861/clinmedicine.7-5-514

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  6 in total

1.  Polypharmacy: one of the greatest prescribing challenges in general practice.

Authors:  Rupert A Payne; Anthony J Avery
Journal:  Br J Gen Pract       Date:  2011-02       Impact factor: 5.386

2.  Polypharmacy among Underserved Older African American Adults.

Authors:  Mohsen Bazargan; James Smith; Masoud Movassaghi; David Martins; Hamed Yazdanshenas; Seyede Salehe Mortazavi; Gail Orum
Journal:  J Aging Res       Date:  2017-05-23

3.  Prevalence of psychoactive substance use among acutely hospitalised patients in Oslo and Moscow: a cross-sectional, observational study.

Authors:  Danil Gamboa; Benedicte Jørgenrud; Evgeny A Bryun; Vigdis Vindenes; Evgenya A Koshkina; Aleksei V Nadezhdin; Saranda Kabashi; Elena J Tetenova; Thomas Berg; Anna Armika Tussilago Nyman; Alexey J Kolgashkin; Aleksei E Petukhov; Sergey N Perekhodov; Elena N Davydova; Anners Lerdal; Gudmund Nordby; Stig Tore Bogstrand
Journal:  BMJ Open       Date:  2020-09-17       Impact factor: 2.692

4.  Identifying enablers and barriers to individually tailored prescribing: a survey of healthcare professionals in the UK.

Authors:  Joanne Reeve; Nicky Britten; Richard Byng; Jo Fleming; Janet Heaton; Janet Krska
Journal:  BMC Fam Pract       Date:  2018-01-15       Impact factor: 2.497

5.  Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing.

Authors:  Majed Alshamrani; Abdullah Almalki; Mohamed Qureshi; Oyindamola Yusuf; Sherine Ismail
Journal:  Pharmacy (Basel)       Date:  2018-07-25

6.  A 3D-Printed Polymer-Lipid-Hybrid Tablet towards the Development of Bespoke SMEDDS Formulations.

Authors:  Bryce W Barber; Camille Dumont; Philippe Caisse; George P Simon; Ben J Boyd
Journal:  Pharmaceutics       Date:  2021-12-07       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.